Clearmind Medicine Inc. Common Shares
Veridion Score
Composite trend over time
Why is CMND moving today?
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CMND.
CMND insider activity
Clearmind Medicine Inc. Common Shares
No multi-insider buying cluster in the last 90 days
Net buying: $212K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 2026-06-16 | HRT FINANCIAL LP | Insider | sell | $3.31 | 22,139 | 81,353 | $73K | SEC Form 4 |
| 2026-06-17 | 2026-06-15 | HRT FINANCIAL LP | Insider | sell | $3.32 | 3,183 | 103,492 | $11K | SEC Form 4 |
| 2026-06-16 | 2026-06-12 | HRT FINANCIAL LP | Insider | sell | $3.36 | 2,102 | 106,675 | $7K | SEC Form 4 |
| 2026-06-12 | 2026-06-11 | HRT FINANCIAL LP | Insider | sell | $0.12 | 225,191 | 1,838,075 | $28K | SEC Form 4 |
| 2026-06-12 | 2026-06-10 | HRT FINANCIAL LP | Insider | buy | $0.15 | 2,159,052 | 2,063,266 | $330K | SEC Form 4 |
CMND contract awards, year to date.
Public federal awards linked to this ticker.
CMND lobbying filings, year to date.
Registered lobbying filings matched to Clearmind Medicine Inc. Common Shares.